NEW YORK (GenomeWeb) The GenomeWeb Index rose 2 percent in June, outperforming the Dow Jones Industrial Average and the Nasdaq which gained less than 2 percent and lost 1 percent, respectively but vastly underperforming the Nasdaq Biotechnology Index, which gained nearly 9 percent.

Stock performance in the June GenomeWeb Index was mostly positive with 19 of the 26 stocks seeing gains and only seven seeing losses.

Registering provides access to this and other free content.

Already have an account? .

Follow this link:
Myriad Genetics Tops June GenomeWeb Index on Positive Insurance Coverage News - GenomeWeb